ALVAL Valbiotis SA
0.6430EUR+0.94%Mkt Cap: 24.81M $P/E: —1d ago
Valbiotis SA engages in the research and development of dietary supplements to prevent metabolic and cardiovascular diseases in France and Asia. The company offers supplements for immunity and vitality, health and wellbe…
Industry Peers
Packaged FoodsKey Statistics
Company
Market Cap24.81M USD
Enterprise Value12.48M USD
Revenue (TTM)983.70K USD
Gross Profit-1.44M USD
Net Income (TTM)-10.24M USD
Revenue/Share0.05 EUR
Last Price0.6430 EUR
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees50
CountryFR
SectorConsumer Defensive
IndustryPackaged Foods
ISINFR0013254851
Valuation
P/E (Trailing)—
P/E (Forward)-7.96
PEG—
EV/EBITDA-1.25
EV/Revenue12.69
P/S24.98
P/B2.17
EPS (TTM)-0.47
EPS (Forward)-0.08
52W Range
0.535014% of range1.296
52W High1.296 EUR
52W Low0.5350 EUR
Profitability
Gross Margin-146.19%
Oper. Margin-844.06%
EBITDA Margin0.00%
Profit Margin-1040.55%
ROE-135.28%
ROA-65.45%
Growth
Revenue Growth305.70%
Earnings Growth—
Cash Flow & Leverage
Operating CF-8.74M USD
CapEx (TTM)164.13K USD
FCF Margin-517.15%
FCF Yield-20.51%
Net Debt-3.90M USD
Net Debt/EBITDA0.39
Balance Sheet
Debt/Equity0.73
Current Ratio2.85
Quick Ratio2.22
Book Value/Sh0.29 EUR
Cash/Share0.37 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 EUR
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.0 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)1.850 EUR
Upside (mean)+187.7%
Target Range1.800 EUR – 1.900 EUR
1.800+187.7% to mean1.900
# Analysts2
Ownership
Shares Out.35.49M
Float22.95M
Insiders2.57%
Institutions1.53%
Technical
SMA 500.7783 (-17.4%)
SMA 2000.8986 (-28.4%)
Beta-0.20
S&P 52W Chg14.58%
Avg Vol (30d)68.67K
Avg Vol (10d)101.84K
Technical Indicators
RSI (14)29.0
MACD-0.0369
MACD Signal-0.0273
MACD Hist.-0.0096
BB Upper0.8371 EUR
BB Middle0.7326 EUR
BB Lower0.6281 EUR
BB Width28.54%
ATR (14)0.0335 EUR
Vol Ratio (20d)0.51x